跳至主要内容
临床试验/CTRI/2022/01/039269
CTRI/2022/01/039269尚未招募未知

Mometasone furoate and fluticasone furoate nasal sprays in treatment of pediatric patients with allergic rhinitis aged 6-18 years: a randomized double blind control trial

Dr Shubham jain0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Children between 6 and 18 years of either gender with history of having or diagnosed allergic rhinitis.Allergic rhinitis is characterized by nasal blockage, rhinorrhea, sneezing and itching; any 2 of the above 4 symptoms must be present for >1hr every day for >2weeks to diagnose allergic rhinitis.
  • Children with allergic rhinitis whose parents could understand and were able to adhere to the dosing and visit schedules and agreed to record the events accurately and consistently.

排除标准

  • Children with any known Comorbid condition.
  • Children with symptoms of rhinitis with fever.
  • Children whose parents do not give consent.
  • Children who are already being treated with intranasal corticosteroids.

研究者

发起方
Dr Shubham jain

相似试验